Coherus Oncology, Inc. Common Stock
CHRS
CHRS
169 hedge funds and large institutions have $348M invested in Coherus Oncology, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 42 funds opening new positions, 63 increasing their positions, 48 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
169
Holders Change
+8
Holders Change %
+4.97%
% of All Funds
2.69%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
42
Increased
63
Reduced
48
Closed
33
Calls
$2.35M
Puts
$1.74M
Net Calls
+$609K
Net Calls Change
+$898K
Top Buyers
| 1 |
1
State Street
Boston,
Massachusetts
|
$32.9M |
| 2 |
2
Barclays
London,
United Kingdom
|
$8.88M |
| 3 |
3
Bank of America
Charlotte,
North Carolina
|
$5.51M |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$36.6M |
| 5 |
5
Rafferty Asset Management
New York
|
$3.28M |
Top Sellers
| 1 |
1
BlackRock
New York
|
$43.6M |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$9.95M |
| 3 |
3
Point72 Asset Management
Stamford,
Connecticut
|
$28K |
| 4 |
4
Millennium Management
New York
|
$810K |
| 5 |
5
VOYA Investment Management
Atlanta,
Georgia
|
$235K |
